Home / Companies / Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

FDA Regulatory Profile

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0260-2021Class IIIAuryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distribJanuary 29, 2021
D-0170-2021Class IIAuryxia (ferric citrate) tablets, 210 mg, 200-count bottles, Rx only, Manufactured for and distributDecember 9, 2020